Maverick Capital’s Keurig Dr Pepper KDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Buy
58,380
+2,557
+5% +$74.5K 0.02% 81
2026
Q1
$1.47M Buy
55,823
+8,369
+18% +$235K 0.02% 103
2025
Q4
$1.33M Sell
47,454
-19,001
-29% -$522K 0.01% 157
2025
Q3
$1.7M Buy
+66,455
New +$2.08M 0.02% 176
2024
Q1
Sell
-25,183
Closed -$839K 484
2023
Q4
$839K Buy
+25,183
New +$785K 0.02% 142
2023
Q3
Sell
-65,358
Closed -$2.04M 412
2023
Q2
$2.04M Sell
65,358
-15,215
-19% -$499K 0.04% 105
2023
Q1
$2.84M Buy
80,573
+68,493
+567% +$2.41M 0.07% 71
2022
Q4
$431K Sell
12,080
-14,625
-55% -$548K 0.01% 207
2022
Q3
$957K Sell
26,705
-9,155
-26% -$346K 0.02% 134
2022
Q2
$1.27M Buy
35,860
+26,213
+272% +$951K 0.03% 121
2022
Q1
$366K Buy
+9,647
New +$366K 0.01% 182
2021
Q2
Sell
-25,033
Closed -$860K 773
2021
Q1
$860K Buy
+25,033
New +$811K 0.01% 289
2020
Q4
Sell
-8,874
Closed -$245K 729
2020
Q3
$245K Buy
+8,874
New +$260K ﹤0.01% 471

Other funds holding KDP

Maverick Capital's KDP Position: Q2 2026 in Review

Maverick Capital increased its Keurig Dr Pepper (KDP) stake by 4.6% in Q2 2026, buying an estimated $74.5K and bringing the position to 58,380 shares worth $1.91M. The position accounts for 0.02% of the portfolio, ranked #81.

Maverick Capital first reported a position in KDP in Q3 2020 and has held it in 13 quarters since. The position peaked at $2.84M in Q1 2023. 851 funds tracked by Wall St. Rank hold KDP as of Q2 2026.

  • Maverick Capital held 58,380 shares of Keurig Dr Pepper worth $1.91M as of Q2 2026.
  • Maverick Capital bought 2,557 Keurig Dr Pepper shares in Q2 2026, an estimated $74.5K.
  • Keurig Dr Pepper made up 0.02% of Maverick Capital's portfolio in Q2 2026, its #81 holding.
  • Maverick Capital first reported a position in Keurig Dr Pepper in Q3 2020 and has held it in 13 quarters since.
  • Maverick Capital's Keurig Dr Pepper position peaked at $2.84M in Q1 2023.
  • 851 funds tracked by Wall St. Rank held Keurig Dr Pepper as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.